stars 1 stars 2 stars 3

biomodal is an omics-based life sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solutions enable more epigenetic information from a single, low input DNA sample without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, resolved sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing. Recognised for our world-class innovation in "The Sunday Times 100 Tech 2026," which showcases the fastest growing UK tech companies, you can learn more at biomodal.com and follow us on LinkedIn.

biomodal Questions

The biomodal annual revenue was $4.2 million in 2026.

Peter Fromen is the CEO of biomodal.

71 people are employed at biomodal.

The NAICS codes for biomodal are [722, 72].

The SIC codes for biomodal are [38, 58, 581, 384].

Top biomodal Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users